Form 8-K - Current report:
SEC Accession No. 0001437749-24-037515
Filing Date
2024-12-16
Accepted
2024-12-13 21:53:05
Documents
42
Period of Report
2024-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20241210_8k.htm   iXBRL 8-K 405491
2 EXHIBIT 3.9 ex_757086.htm EX-3.9 2279
3 EXHIBIT 3.10 ex_757087.htm EX-3.10 1103
4 EXHIBIT 3.11 ex_757088.htm EX-3.11 2936
5 EXHIBIT 4.1 ex_755588.htm EX-4.1 1779
6 EXHIBIT 10.22 ex_756051.htm EX-10.22 67798
7 EXHIBIT 10.23 ex_756052.htm EX-10.23 68191
8 EXHIBIT 10.24 ex_757081.htm EX-10.24 40308
9 EXHIBIT 10.26 ex_755589.htm EX-10.26 172777
10 EXHIBIT 10.27 ex_755590.htm EX-10.27 245014
11 EXHIBIT 10.29 ex_755591.htm EX-10.29 38591
12 EXHIBIT 10.30 ex_755592.htm EX-10.30 29431
13 EXHIBIT 14.1 ex_756585.htm EX-14.1 103070
14 EXHIBIT 21.1 ex_757064.htm EX-21.1 4214
15 EXHIBIT 99.1 ex_757117.htm EX-99.1 23937
16 EXHIBIT 99.2 ex_755593.htm EX-99.2 350817
17 EXHIBIT 99.3 ex_755594.htm EX-99.3 614219
18 EXHIBIT 99.4 ex_755595.htm EX-99.4 382600
23 cert1.jpg GRAPHIC 140038
24 cert02.jpg GRAPHIC 373591
25 ex_39page1.jpg GRAPHIC 538427
26 ex_39page2.jpg GRAPHIC 489056
27 ex_39page3.jpg GRAPHIC 487089
28 ex_310.jpg GRAPHIC 555121
29 exhibit311_page1.jpg GRAPHIC 545932
30 exhibit311_page2.jpg GRAPHIC 448616
31 exhibit311_page3.jpg GRAPHIC 450517
32 exhibit311_page4.jpg GRAPHIC 389269
33 plogo.jpg GRAPHIC 10074
  Complete submission text file 0001437749-24-037515.txt   9122597

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA pvla-20241213.xsd EX-101.SCH 3410
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvla-20241213_def.xml EX-101.DEF 12628
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvla-20241213_lab.xml EX-101.LAB 17059
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvla-20241213_pre.xml EX-101.PRE 12953
44 EXTRACTED XBRL INSTANCE DOCUMENT pirs20241210_8k_htm.xml XML 3218
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 241549973
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)